Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
1.25+/-1.09, p=0.569), or HAM-A scores at endpoint (3.30+/-2.89 vs.
Tacrolimus ointment therapy resulted in the full symptom relief of eczema, this effect of tacrolimus ointment strengths 0.03% and 0.1% were better than those of 1% hydrocortisone acetate and 1% pimecrolimus.
Findings from this pilot project suggest that bupropion XL may be useful in treating GAD.
Transdermal estradiol alone or associated with medroxyprogesterone acetate decreased plasma levels of F2alpha-isoprostanes.
The use of variable dosing in PMED increases the effectiveness of treatment.
Finasteride 1 mg treatment led to a 93% decrease relative to placebo in the 5-year likelihood of developing further visible hair loss (95% CI: 89-97%; p < 0.001).
At doses producing equivalent hypotensive effects, telmisartan apparently had a more favorable effect on functional parameters related to endothelial function than did valsartan.
We believe that 5% MTF is a safe and effective treatment for men with AGA.
The 3 by 3 factorial design was applied for this purpose and the approach for calculating sample size was proposed.
Continuous combined HRT was effective for the relief of climacteric symptoms in early postmenopausal women and was well tolerated.
Only response inhibition, a fundamental executive function, predicted poor treatment response to antidepressant medication.
These results demonstrate enhancement of the antidepressant effect of sertraline by concurrent treatment with liothyronine without a significant increase in adverse effects.
Greater reductions in LDL-C were achieved with rosuvastatin compared with equal doses of atorvastatin, enabling more patients with Type 2 diabetes to achieve European LDL-C goals.
Testosterone replacement treatment decreases leptin and adiponectin levels in type 2 diabetic men.
The real-world benefits and safety of extended-release metformin within 12 week treatment for type 2 diabetes is comparable to those of Glucophage treatment with good compliance and mild adverse side effects.
Approximately 19 g of lipid per meal efficiently increases absorption of testosterone from oral TU.
In depressed patients with persistent symptoms after an initial trial of sertraline, addition of atomoxetine did not improve response more than placebo.
Tadalafil once daily was well tolerated and demonstrated clinically meaningful and statistically significant symptomatic improvement for lower urinary tract symptoms/benign prostatic hyperplasia.
Replacement of oestradiol and progesterone was not effective for prevention of BPD or death in extremely preterm born infants.
Platelet reactivity and a proinflammatory chemokine were reduced more by the higher atorvastatin dose than by ezetimibe plus low-dose atorvastatin.
Combination rosuvastatin with ezetimibe 10 mg enabled greater decreases in LDL cholesterol and allowed more patients to achieve LDL cholesterol goals.
The congruence of patients' treatment preference and the treatment that they ultimately received influenced the development of the therapeutic alliance.
Melatonin advanced circadian rhythms of sleep-wake and endogenous melatonin and enhanced total time asleep in children with ADHD and chronic sleep onset trouble sleeping; however, no effect was found on problem behavior,...
There was a strong positive correlation between serum and intraprostatic dutasteride concentrations (R(2)=0.73).
CD62P was significantly reduced after losartan treatment (P = .016), but no significant differences were noted with telmisartan.
Sertraline is an effective antidepressant for postmenopausal women with MDD.
Our data revealed that treatment with telmisartan even at a low dose improves insulin sensitivity in hypertensive patients with MetS.
Bupropion treatment was associated with significant improvements in depression and anxiety symptoms in asthma patients.
Dutasteride increases scalp hair growth in men with MPHL.
After four months treatment, both groups showed a significant reduction of mean blood pressure (Group A: - 13.5%; Group B: - 13.3%) and a positive influence on glycaemic control and insulin resistance.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
